Male hypogonadism and pre-diabetes interplay: association or causal interaction? A systematic review

Abstract

Aim: The association between type 2 diabetes mellitus (T2DM) and male hypogonadism has been largely demonstrated. Testosterone (T) serum levels are often lower in men with T2DM compared to the general population, and, conversely, men with higher T serum levels have shown lower risk of T2DM. On the contrary, the association between pre-diabetes and male hypogonadism has been less investigated thus far. Pre-diabetes is a common clinical condition preceding T2DM and has been recognized as a potential risk factor for other metabolic disorders and cardiovascular diseases. Therefore, the aims of this review are to investigate the association between pre-diabetes and male hypogonadism and to evaluate the potential effect of T treatment on glucose metabolism and anti-diabetic therapy on T serum levels.

Methods: We conducted this systematic review developing different literature searches, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocol.

Results: In our analysis, male hypogonadism has a prevalence of around 24%-35% in pre-diabetic men. Moreover, we observed improvement of metabolic parameters in pre-diabetes with T treatment. On the contrary, anti-diabetic therapy seems to have no particular effects on T serum levels.

Conclusion: Overall, we demonstrated that, although T administration could be considered in pre-diabetic men, pre-diabetes-related treatments should be confined to the control glucose metabolism, since no evidence for a positive effect on total T serum levels is available. Future research should be oriented to study the role of new anti-diabetic drugs in the sex hormonal status in hypogonadal men.

Keywords

Hypogonadism / testosterone / pre-diabetes

References

[1] Bebb R,Brock G.Diabetes Canada Clinical Practice Guidelines Expert CommitteeSexual dysfunction and hypogonadism in men with diabetes.Can J Diabetes2018;42 Suppl 1:S228-33

[2] Dhindsa S,Batra M.Hypogonadotropic hypogonadism in men with diabesity.Diabetes Care2018;41:1516-25 PMCID:PMC6014549

[3] Rochira V.Hypogonadism in systemic diseases. In: Simoni M, Huhtaniemi I, editors. Endocrinology of the testis and male reproduction. Cham: Springer International Publishing; 2017. p. 1-51.

[4] Ding EL,Malik VS.Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.JAMA2006;295:1288-99

[5] Atlantis E,Martin S.Predictive value of serum testosterone for type 2 diabetes risk assessment in men.BMC Endocr Disord2016;16:26 PMCID:PMC4882776

[6] Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021.Diabetes Care2021;44:S15-33

[7] World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Available from: https://apps.who.int/iris/bitstream/handle/10665/43588/9241594934_eng.pdf [Last accessed on 29 Nov 2021]

[8] Tabák AG,Rathmann W,Kivimäki M.Prediabetes: a high-risk state for diabetes development.Lancet2012;379:2279-90 PMCID:PMC3891203

[9] Alvarez S,Algotar AM.Prediabetes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.

[10] Sörensen BM,Berendschot TT.Prediabetes and type 2 diabetes are associated with generalized microvascular dysfunction: the maastricht study.Circulation2016;134:1339-52

[11] Ford ES,Li C.Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence.J Am Coll Cardiol2010;55:1310-7

[12] Corona G,Balercia G.Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study.J Sex Med2012;9:1669-80

[13] Buysschaert M,Bergman M,Lonier J.Prediabetes and associated disorders.Endocrine2015;48:371-93

[14] Greco C.Obstructive sleep apnoea syndrome and diabetes. Fortuitous association or interaction?.Curr Diabetes Rev2015;12:129-55

[15] Decaroli MC.Aging and sex hormones in males.Virulence2017;8:545-70 PMCID:PMC5538340

[16] Wu FC,Beynon JM.EMAS GroupIdentification of late-onset hypogonadism in middle-aged and elderly men.N Engl J Med2010;363:123-35

[17] Basaria S.Male hypogonadism.Lancet2014;383:1250-63

[18] Bhasin S,Cunningham GR.Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline.J Clin Endocrinol Metab2018;103:1715-44

[19] Swiecicka A, Wu F. Clinical manifestation and diagnosis of androgen deficiency. In: Simoni M, Huhtaniemi I, Editors. Endocrinology of the testis and male reproduction. Cham: Springer International Publishing; 2017. p. 1-18.

[20] Dean JD,Guay AT.The international society for sexual medicine's process of care for the assessment and management of testosterone deficiency in adult men.J Sex Med2015;12:1660-86

[21] Hackett G,Edwards D.British society for sexual medicine guidelines on adult testosterone deficiency, with statements for UK practice.J Sex Med2017;14:1504-23

[22] Wang C,Swerdloff R.International Society of Andrology (ISA), International Society for the Study of Aging Male (ISSAM), European Association of Urology (EAU), European Academy of Andrology (EAA), American Society of Andrology (ASA)Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.J Androl2009;30:1-9

[23] Salonia A,Boeri L.EAU Working Group on Male Sexual and Reproductive HealthEuropean Association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction.Eur Urol2021;80:333-57

[24] Bhasin S,Jasuja GK.Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts.J Clin Endocrinol Metab2011;96:2430-9 PMCID:PMC3146796

[25] Huhtaniemi IT,Lee DM.EMAS GroupComparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men.Eur J Endocrinol2012;166:983-91

[26] Frost M,Nielsen TL.Similar reference intervals for total testosterone in healthy young and elderly men: results from the Odense Androgen Study.Clin Endocrinol (Oxf)2013;78:743-51

[27] Sartorius G,Idan A.Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study.Clin Endocrinol (Oxf)2012;77:755-63

[28] Grossmann M.Functional hypogonadism in middle-aged and older men: testosterone treatment or not?.Eur J Endocrinol2021;185:D1-9

[29] Gyawali P,Heilbronn LK.The role of sex hormone-binding globulin (SHBG), testosterone, and other sex steroids, on the development of type 2 diabetes in a cohort of community-dwelling middle-aged to elderly men.Acta Diabetol2018;55:861-72

[30] Hu J,Yang S.Combined effects of sex hormone-binding globulin and sex hormones on risk of incident type 2 diabetes.J Diabetes2016;8:508-15

[31] Yao QM,An XF,Ding L.Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis.Endocr Connect2018;7:220-31 PMCID:PMC5793809

[32] Malipatil NS,Lunt M.Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetes.Endocrinol Diabetes Metab2019;2:e00064 PMCID:PMC6613223

[33] Zhang J,Cai Z,Yang B.Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis.Aging Male2020;23:607-18

[34] Simon D,Barrett-Connor E.Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study.Diabetologia1992;35:173-7

[35] Pitteloud N,Dwyer AA.Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.J Clin Endocrinol Metab2005;90:2636-41

[36] Contreras PH,Salgado AM.Insulin sensitivity and testicular function in a cohort of adult males suspected of being insulin-resistant.Front Med (Lausanne)2018;5:190 PMCID:PMC6028607

[37] Pitteloud N,Dwyer AA.Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.Diabetes Care2005;28:1636-42

[38] Grossmann M,Panagiotopoulos S.Low testosterone levels are common and associated with insulin resistance in men with diabetes.J Clin Endocrinol Metab2008;93:1834-40

[39] Souteiro P,Oliveira SC.AMTCO GroupInsulin resistance and sex hormone-binding globulin are independently correlated with low free testosterone levels in obese males.Andrologia2018;50:e13035

[40] Arthur R,Møller H.Pre-diabetes and serum sex steroid hormones among US men.Andrology2017;5:49-57

[41] Oh JY,Wedick NM.Rancho Bernardo StudyEndogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study.Diabetes Care2002;25:55-60

[42] Dandona P,Ghanim H.Mechanisms underlying the metabolic actions of testosterone in humans: a narrative review.Diabetes Obes Metab2021;23:18-28

[43] Corona G,Maseroli E.Testosterone supplementation and body composition: results from a meta-analysis of observational studies.J Endocrinol Invest2016;39:967-81

[44] Corona G,Maseroli E.Therapy of endocrine disease: testosterone supplementation and body composition: results from a meta-analysis study.Eur J Endocrinol2016;174:R99-116

[45] Isidori AM,Greco EA.Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.Clin Endocrinol (Oxf)2005;63:280-93

[46] Rabijewski M,Piątkiewicz P.The relationships between anabolic hormones and body composition in middle-aged and elderly men with prediabetes: a cross-sectional study.J Diabetes Res2016;2016:1747261 PMCID:PMC4868895

[47] Caliber M.Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosterone.Curr Opin Pharmacol2021;58:83-9

[48] Wittert G,Robledo KP.Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.Lancet Diabetes Endocrinol2021;9:32-45

[49] Haider KS,Saad F.Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.Diabetes Obes Metab2020;22:2055-68 PMCID:PMC7689919

[50] Mårin P,Björntorp P.Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens.J Clin Endocrinol Metab1995;80:239-43

[51] Singh R,Taylor WE.Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.Endocrinology2006;147:141-54 PMCID:PMC4417624

[52] Singh R,Taylor WE,Bhasin S.Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway.Endocrinology2003;144:5081-8

[53] Dyson PA.The therapeutics of lifestyle management on obesity.Diabetes Obes Metab2010;12:941-6

[54] Benvenuti S,Luciani P.Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells.J Endocrinol Invest2012;35:365-71

[55] Abdelzaher WY,Ali DME.Protective effect of dipeptidyl peptidase-4 inhibitors in testicular torsion/detorsion in rats: a possible role of HIF-1α and nitric oxide.Naunyn Schmiedebergs Arch Pharmacol2020;393:603-14

[56] Rabijewski M,Piątkiewicz P.Late-onset hypogonadism among old and middle-aged males with prediabetes in Polish population.Aging Male2015;18:16-21

[57] Boeri L,Pederzoli F.Unrecognized prediabetes is highly prevalent in men with erectile dysfunction-results from a cross-sectional study.J Sex Med2018;15:1117-24

[58] Boeri L,Ventimiglia E.Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study.BJU Int2019;123:1070-7

[59] Ho CH,Wang CY.Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome.PLoS One2013;8:e74173 PMCID:PMC3772062

[60] Zhu H,Han B.Low Sex Hormone-binding globulin levels associate with prediabetes in chinese men independent of total testosterone.PLoS One2016;11:e0162004 PMCID:PMC5008813

[61] Goodman-Gruen D.Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women.Diabetes Care2000;23:912-8

[62] Lu Y,Cheng X.Testosterone level in aging male with different glucose tolerance state and its association with osteocalcin.Aging Male2019;22:68-73

[63] Colangelo LA,Liu K.Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis.Diabetes Care2009;32:1049-51 PMCID:PMC2681025

[64] Liu X,Liu X.Association of serum testosterone with different classes of glucose metabolism and the mediation effect of obesity: the henan rural cohort study.Diabetes Metab Res Rev2019;35:e3133

[65] Chen X,Liu L,Yu X.Osteocalcin is inversely associated with glucose levels in middle-aged Tibetan men with different degrees of glucose tolerance.Diabetes Metab Res Rev2014;30:476-82

[66] Minooee S,Rahmati M.The association between serum total testosterone and progression of hyperglycemia: a 15-year prospective cohort study.Andrology2019;7:148-55

[67] Rabijewski M,Piątkiewicz P.The prevalence of prediabetes in population of Polish men with late-onset hypogonadism.Aging Male2014;17:141-6

[68] Krysiak R,Okopien B.The effect of metformin and metformin-testosterone combination on cardiometabolic risk factors in men with late-onset hypogonadism and impaired glucose tolerance.Exp Clin Endocrinol Diabetes2015;123:608-13

[69] Yassin A,Haider KS.Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study.Diabetes Care2019;42:1104-11

[70] Strollo F,Morè M.Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.Aging Male2013;16:33-7

[71] Krysiak R,Bednarska-Czerwińska A.Plasma gonadotropin levels in metformin-treated men with prediabetes: a non-randomized, uncontrolled pilot study.Fundam Clin Pharmacol2021;35:466-72

[72] Stellato RK,Hamdy O,McKinlay JB.Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study.Diabetes Care2000;23:490-4

[73] Ottarsdottir K,Hellgren M,Daka B.The association between serum testosterone and insulin resistance: a longitudinal study.Endocr Connect2018;7:1491-500 PMCID:PMC6311464

[74] Buvat J,Gooren L.Endocrine aspects of male sexual dysfunctions.J Sex Med2010;7:1627-56

[75] Boeri L,Ventimiglia E.Sexual dysfunction in men with prediabetes.Sex Med Rev2020;8:622-34

[76] Rastrelli G,Ahern T.EMAS study groupSymptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: prospective results from the EMAS.Clin Endocrinol (Oxf)2018;89:459-69

[77] Filippi S,Morelli A.Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome.J Sex Med2009;6:3274-88

[78] Ballester J,Domínguez J,Guinovart JJ.Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms.J Androl2004;25:706-19

[79] Vignozzi L,Filippi S.Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes.J Sex Med2007;4:620-32

[80] Brüning JC,Burks DJ.Role of brain insulin receptor in control of body weight and reproduction.Science2000;289:2122-5

[81] Khaw K.Lower endogenous androgens predict central adiposity in men.Ann Epidemiol1992;2:675-82

[82] Pasquali R,Cantobelli S.Effect of obesity and body fat distribution on sex hormones and insulin in men.Metabolism1991;40:101-4

[83] Mårin P,Gustafsson C.Androgen treatment of abdominally obese men.Obes Res1993;1:245-51

[84] Mårin P,Jönsson L.The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.Int J Obes Relat Metab Disord1992;16:991-7

[85] Dhindsa S,Sethi M,Chaudhuri A.Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.J Clin Endocrinol Metab2004;89:5462-8

[86] Dhindsa S,Batra M.Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes.Diabetes Care2016;39:82-91 PMCID:PMC4686848

[87] Schlesinger S,Barbaresko J.Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies.Diabetologia2021;

[88] Giagulli VA,Carbone MD.Weight loss more than glycemic control may improve testosterone in obese type 2 diabetes mellitus men with hypogonadism.Andrology2020;8:654-62

[89] Ognjenovic M,Malacova E.Associations between major dietary patterns and testicular function in a population-based cohort of young men: results from the Western Australian Pregnancy Cohort (Raine) Study.Andrology2019;7:273-80

[90] Grossmann M,Nie T.Changes in white adipose tissue gene expression in a randomized control trial of dieting obese men with lowered serum testosterone alone or in combination with testosterone treatment.Endocrine2021;73:463-71

[91] Steeves JA,Bradwin G,Platz EA.Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004.Andrology2016;4:465-72 PMCID:PMC5808848

[92] Kanakis GA,Goulis DG.Measuring testosterone in women and men.Maturitas2019;125:41-4

[93] Krone N,Lavery GG,Arlt W.Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS).J Steroid Biochem Mol Biol2010;121:496-504 PMCID:PMC2941839